Announcement
Please be aware there are phishing emails pretending to be from AIiH organisers. Please check the email sender address very carefully (contact@aiih.cc and the emails from dedicated CMT submission site are our official channels of communication). If in any doubt, please seek clarification from contact@aiih.cc
Conference Programme is now available!
AIiH 2026 has accepted 8 special session proposals. More details can be found from following the main menu item “Calls”.
This year, AIiH launches a brand new challenge of Perivascular Space Segmentation. Full details can be found here.
Welcome to AIiH 2026
We are delighted to invite you to take part in the third International Conference on Artificial Intelligence in Healthcare (AIiH 2026), which will be held in the Imperial College London from Wednesday 26 August to Friday 28 August 2026. The previous two editions of the AIiH series were successfully held in the beautiful city of Swansea in September 2024 and in the University of Cambridge in September 2025.
AIiH aims to provide a prominent platform for researchers and practitioners who are devoted to improving healthcare using modern artificial intelligence. We recognise that healthcare applications present complex and sometimes unique challenges across a wide spectrum, from ethics to technical developments, that generic AI methods are often inadequate. By creating this dedicated forum, we encourage discussions and disseminations of efficient and effective AI solutions and technologies for healthcare, and in turn we hope to influence the research, technology adoption, and decision making in healthcare.
The conference welcomes submissions of novel research work in the following areas, but not limited to:
- Ethics of AI in Healthcare
- Predictive Analytics in Healthcare
- AI driven proactive care and predictive intervention
- AI driven early diagnosis and prevention
- Machine and deep learning approaches for health data
- AI-aided signal processing
- AI-aided medical imaging (CT, MRI, ultrasound, histopathology, etc.)
- Medical image analysis and processing
- Digital and virtual pathology / neurology
- AI in Pharmacology: drug discovery and drug development
- AI driven Digital Twinning in Oncology/Medicine
- Precision Medicine and AI
- AI for drug screening and discovery
- AI led personalised healthcare
Conference Proceedings
AIiH 2026 continues working with Springer in publishing its conference proceedings. Accepted full-length papers of AIiH 2025 and AIiH 204 are published in Springer LNCS series.
The conference also welcomes submission of short abstracts, which will be archived on zonodo.org (with DOIs) together with previously accepted short abstracts.
Best Paper Special Issue
The winners of the Best Paper Award and the runner-up(s) will be invited to submit extended versions to the journal of Big Data Mining and Analytics (BDMA). BDMA has an impact factor of 6.2 and publishes state-of-the-art big data research and their applications, including healthcare.
This prestigious best paper award is to recognise the outstanding scientific quality of the work presented at the AIiH. The work must show outstanding scientific rigour, major novelty, and comprehensive comparative analysis. It is awarded based on Programme Chairs’ and reviewers’ recommendations. Presentation quality is also taken into consideration. The winners of AIiH 2025 can be found here and those of AIiH 2024 can be found here. The AIiH 2026 special issue is to be available in early 2027.
Keynote Speakers
Conference Tutorial:
Translating AI to Clinical Practices
Stephen Smith, University of York
DoRa-PVS Challenge
AIiH 2026 launches a new challenge for our scientific community: The Domain Randomisation Challenge for Perivascular Space Segmentation
This challenge aims to identify the most effective domain randomisation strategies for achieving robust out-of-sample PVS segmentation. Rather than just benchmarking different deep learning architectures, we focus also on comparing domain randomisation strategies.
Evaluation will be conducted entirely out-of-sample using MRI data acquired at 1.5T, 3T, and 7T with both isotropic and anisotropic resolutions. The test datasets originate from cohorts spanning a wide spectrum of clinical conditions, including normal cognition, sleep deprivation, post-COVID syndrome, hypertensive arteriopathy, cerebral amyloid angiopathy, heart failure, mild cognitive impairment, Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. This heterogeneous evaluation design ensures that successful methods demonstrate robustness across scanners, populations, and clinical contexts.
Conference Venue
The conference main venue is the Blackett Laboratory at Imperial College London. All the oral sessions will take place there. The poster session will take place in the Royal Geographical Society, which is only 5-minute walk away from the main venue. The conference banquet will be hosted in the Great Hall at King’s College London. To reach the conference venue, please use the entrance on Prince Consort Road, next to the Royal Albert Hall, marked on the map below.
Sponsors
Gold Sponsor (invited speaker sponsorships)
Best Paper Award Sponsor